Literature DB >> 24170285

[Image-guided therapy with closed MRI: an update].

R Hoffmann1, H Rempp, P L Pereira, S Clasen.   

Abstract

STANDARD RADIOLOGICAL
METHODS: Standard imaging modalities for percutaneous minimally invasive therapy are ultrasound, fluoroscopy and computed tomography. METHODICAL INNOVATIONS: Magnetic resonance imaging is becoming increasingly more popular for minimally invasive procedures. The advantages are high soft-tissue contrast, the possibility of free selection of multiple imaging slices, multiple tools for intrainterventional monitoring and the absence of ionizing radiation for the patient and the interventional radiologist. ACHIEVEMENTS: Magnetic resonance imaging is a promising imaging modality for minimally invasive procedures. The most common clinical applications are thermoablative procedures for treatment of hepatic, renal and prostatic malignancies.

Entities:  

Mesh:

Year:  2013        PMID: 24170285     DOI: 10.1007/s00117-012-2461-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  29 in total

1.  Performing MR-guided biopsies in clinical routine: factors that influence accuracy and procedure time.

Authors:  Rüdiger Hoffmann; Christoph Thomas; Hansjörg Rempp; Diethard Schmidt; Philippe L Pereira; Claus D Claussen; Stephan Clasen
Journal:  Eur Radiol       Date:  2011-09-30       Impact factor: 5.315

Review 2.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

3.  Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging.

Authors:  Konstantin Holzapfel; Melanie Bruegel; Matthias Eiber; Carl Ganter; Tibor Schuster; Petra Heinrich; Ernst J Rummeny; Jochen Gaa
Journal:  Eur J Radiol       Date:  2009-06-06       Impact factor: 3.528

4.  Real-time magnetic resonance imaging of laser heat deposition in tissue.

Authors:  A R Bleier; F A Jolesz; M S Cohen; R M Weisskoff; J J Dalcanton; N Higuchi; D A Feinberg; B R Rosen; R C McKinstry; S G Hushek
Journal:  Magn Reson Med       Date:  1991-09       Impact factor: 4.668

5.  Rapid freehand MR-guided percutaneous needle interventions: an image-based approach to improve workflow and feasibility.

Authors:  Eva Rothgang; Wesley D Gilson; Frank Wacker; Joachim Hornegger; Christine H Lorenz; Clifford R Weiss
Journal:  J Magn Reson Imaging       Date:  2013-01-18       Impact factor: 4.813

Review 6.  Focal therapy for prostate cancer: possibilities and limitations.

Authors:  Scott Eggener; Georg Salomon; Peter T Scardino; Jean De la Rosette; Thomas J Polascik; Simon Brewster
Journal:  Eur Urol       Date:  2010-03-26       Impact factor: 20.096

7.  MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies.

Authors:  Kashif Siddiqui; Rajiv Chopra; Siddharth Vedula; Linda Sugar; Masoom Haider; Aaron Boyes; Mireia Musquera; Michael Bronskill; Laurence Klotz
Journal:  Urology       Date:  2010-08-14       Impact factor: 2.649

8.  Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002.

Authors:  Matthew R Cooperberg; Sanjukta Modak; Badrinath R Konety
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

9.  MR imaging-guided focal cryoablation in patients with recurrent prostate cancer.

Authors:  Joyce G R Bomers; Derya Yakar; Christiaan G Overduin; J P Michiel Sedelaar; Henk Vergunst; Jelle O Barentsz; Frank de Lange; Jurgen J Fütterer
Journal:  Radiology       Date:  2013-03-22       Impact factor: 11.105

10.  Magnetic resonance imaging of the liver: true fast imaging with steady state free precession sequence facilitates rapid and reliable distinction between hepatic hemangiomas and liver malignancies.

Authors:  Kirsti Numminen; Juha Halavaara; Helena Isoniemi; Pekka Tervahartiala; Leena Kivisaari; Jussi Numminen; Krister Höckerstedt
Journal:  J Comput Assist Tomogr       Date:  2003 Jul-Aug       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.